Suppurative thrombophlebitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
Medical therapy of Suppurative thrombophlebitis aims to eliminate the source of infection, followed by antibiotic coverage for the detected pathogen. Surgical intervention, anticoagulation is considered after evaluation of the case. | Medical therapy of Suppurative thrombophlebitis aims to eliminate the source of infection, followed by antibiotic coverage for the detected pathogen. Surgical intervention, anticoagulation is considered after evaluation of the case. | ||
===Peripheral Vein Suppurative | ===Peripheral Vein Suppurative Thrombophlebitis=== | ||
Till the blood culture results detect the targeted pathogen, empiric antibiotic therapy is given aiming to include an agent with activity against [[staphylococci]] plus an agent with activity against [[enterobacteriaceae]]. | Till the blood culture results detect the targeted pathogen, empiric antibiotic therapy is given aiming to include an agent with activity against [[staphylococci]] plus an agent with activity against [[enterobacteriaceae]]. | ||
| Line 13: | Line 13: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Peripheral Vein Suppurative | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Peripheral Vein Suppurative Thrombophlebitis}}'' | ||
|- | |- | ||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 15 to 20 mg/kg/dose every 8 to 12 hours, not to exceed 2 g per dose x minimum of 2Wks ''''' | | style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 15 to 20 mg/kg/dose every 8 to 12 hours, not to exceed 2 g per dose x minimum of 2Wks ''''' | ||
| Line 20: | Line 20: | ||
|- | |- | ||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV daily x minimum of 2Wks''''' | | style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV daily x minimum of 2Wks''''' | ||
|- | |||
|} | |||
|} | |||
===Jugular Vein Suppurative Thrombophlebitis=== | |||
A beta-lactamase resistant beta-lactam antibiotic should be used in cases of jugular vein suppurative thrombophlebitis. | |||
{| | |||
| valign=top | | |||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Jugular Vein Suppurative Thrombophlebitis}}'' | |||
|- | |||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[ampicillin-sulbactam|Ampicillin-sulbactam]] 3 g every six hours x 4 Wks ''''' | |||
|- | |||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | OR | |||
|- | |||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Piperacillin|Piperacillin-tazobactam]] 4.5 g every six hours x 4 Wks''''' | |||
|- | |||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | OR | |||
|- | |||
|style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[ticarcillin|Ticarcillin-clavulanate]] 3.1 g every six hours x 4 Wks''''' | |||
|- | |||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | PLUS | |||
|- | |||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 15 to 20 mg/kg/dose every 8 to 12 hours, not to exceed 2 g per dose x 4 Wks ''''' | |||
|- | |- | ||
|} | |} | ||
Revision as of 13:14, 27 January 2014
|
Suppurative thrombophlebitis Microchapters |
|
Differentiating Suppurative thrombophlebitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Suppurative thrombophlebitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Suppurative thrombophlebitis medical therapy |
|
Directions to Hospitals Treating Suppurative thrombophlebitis |
|
Risk calculators and risk factors for Suppurative thrombophlebitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Overview
Medical therapy of Suppurative thrombophlebitis aims to eliminate the source of infection, followed by antibiotic coverage for the detected pathogen. Surgical intervention, anticoagulation is considered after evaluation of the case.
Peripheral Vein Suppurative Thrombophlebitis
Till the blood culture results detect the targeted pathogen, empiric antibiotic therapy is given aiming to include an agent with activity against staphylococci plus an agent with activity against enterobacteriaceae.
|
Jugular Vein Suppurative Thrombophlebitis
A beta-lactamase resistant beta-lactam antibiotic should be used in cases of jugular vein suppurative thrombophlebitis.
|